Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. is dated April 15, 2024. The report serves to furnish the Notice of Meeting, Proxy Statement, and Proxy Card for the Annual and Special General Meeting of Shareholders scheduled for May 20, 2024. The filing incorporates these documents by reference into the company's existing Registration Statements on Form F-3 and Form S-8.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notification regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The primary content is the announcement of the upcoming shareholder meeting and the eligibility criteria for voting (shareholders of record as of May 20, 2024).
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It strictly outlines the procedural details for the Annual and Special General Meeting.
Key Facts for Investors to Verify
- The Annual and Special General Meeting is scheduled for Monday, May 20, 2024.
- Only shareholders of record holding Ordinary Shares at the close of business on May 20, 2024, are entitled to vote.
- Exhibits 99.1, 99.2, and 99.3 contain the full Notice, Proxy Statement, and Proxy Card respectively.
- This filing updates the company's active registration statements (Form F-3 and Form S-8) by reference.